Release Date: 18/07/18 19:29 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 4.23MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%